ZOFRAN ODT Drug Patent Profile
✉ Email this page to a colleague
When do Zofran Odt patents expire, and what generic alternatives are available?
Zofran Odt is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in ZOFRAN ODT is ondansetron. There are twenty-eight drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the ondansetron profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zofran Odt
A generic version of ZOFRAN ODT was approved as ondansetron by CHARTWELL MOLECULES on December 26th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZOFRAN ODT?
- What are the global sales for ZOFRAN ODT?
- What is Average Wholesale Price for ZOFRAN ODT?
Summary for ZOFRAN ODT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 136 |
Clinical Trials: | 161 |
Patent Applications: | 4,848 |
Drug Prices: | Drug price information for ZOFRAN ODT |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ZOFRAN ODT |
DailyMed Link: | ZOFRAN ODT at DailyMed |


Recent Clinical Trials for ZOFRAN ODT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tanta University | Phase 3 |
Tanta University | Phase 2/Phase 3 |
Emory University | Phase 2 |
US Patents and Regulatory Information for ZOFRAN ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-001 | Jan 27, 1999 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZOFRAN ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | 5,955,488*PED | ⤷ Try for Free |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-001 | Jan 27, 1999 | 4,695,578*PED | ⤷ Try for Free |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | 5,578,628*PED | ⤷ Try for Free |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | 4,695,578*PED | ⤷ Try for Free |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | 6,063,802*PED | ⤷ Try for Free |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-001 | Jan 27, 1999 | 5,955,488*PED | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZOFRAN ODT
See the table below for patents covering ZOFRAN ODT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 583343 | ⤷ Try for Free | |
China | 1080118 | ⤷ Try for Free | |
Finland | 84349 | ⤷ Try for Free | |
Finland | 850323 | ⤷ Try for Free | |
Netherlands | 8500202 | ⤷ Try for Free | |
United Kingdom | 9523667 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for ZOFRAN ODT
More… ↓